Using a variety of adherence measures allows examination of the known inaccuracies of patient self-report with respect to glaucoma medication.
13– 16 Chan et al. 17 reported that surface pigments on Cos-CL resulted in significantly higher bacterial adherence after the examination of 15 commercially available Cos-CLs.
The use of multiple adherence measures allows examination of both intentional and unintentional non-adherence, as prescription refill, FMD and TDA data provide a quantitative estimate of non-adherence whilst the MMAS provides some information about the reason for the non-adherence.
In the first 12 weeks after enrollment, patients were scheduled to be seen at 2, 4, 8, and 12 weeks for adherence counseling, clinical examination, and TB symptom screening.
Insufficient re-examination adherence was defined as having less than the recommended three sputum smear examinations during the treatment course.
Furthermore, protocol adherence was examined.
Independent risk factors associated with incomplete adherence to re-examinations were province, experiencing adverse effects, and not having a DOT observer at home.
In univariate analysis, factors associated with incomplete adherence to re-examinations were province, male gender, adverse effects during treatment, return trip costs to the diagnostic and re-examination center > 20 RMB, no supervision visits by (village) doctor during treatment, and not having a DOT observer during treatment at homeland (Table 3).
Behaviour is measured by 6 items using a timeframe of "the last 6 months", regarding: breast self-examination; adherence to population screening; breast screening by a physician; mammography screening (own initiative); consulting a specialist about a preventive breast operation; preventive breast operation.
Intention is measured using 7 self-developed items regarding: breast self-examination; adherence to population mammography screening (above 50 years of age); breast screening by a physician every 6 months; mammography screening every year (own initiative); DNA testing; having a preventive breast operation (mastectomy); informing close relatives.
